Why do lab-grown cancer cells differ from those in the body?

Question

Accepted Answer

Lab-grown cancer cells differ from those in the body because they are isolated and lack the defences and complex conditions of a living person.

Lab-grown cancer cells grown in small plastic dishes are isolated and defenceless, so they do not have to face the complexities of the human body. In the lab, a compound can often reach the cells directly at a high concentration, which can produce dramatic effects. Inside a living person, the same compounds must survive a difficult journey to reach target tissues.
Lab dishes isolate cancer cells from the body’s defences
In laboratory experiments, cancer cells are grown in controlled conditions where they are “isolated and defenceless.” That means they do not encounter the living body’s protective systems that would normally interact with abnormal cells. As a result, laboratory results can look striking when substances stop growth or even kill the cells in the dish.
Compounds can reach lab cells at higher effective concentrations
In the lab dish setup, a compound can directly reach the cancer cells at a high concentration. This straightforward exposure is one reason why headlines can appear quickly after laboratory findings show strong effects. The living body is different because the compound must travel through multiple barriers before it can affect tumour tissue.
Bioavailability limits how much reaches the target tissue in humans
When food or herbal products are consumed, active compounds must survive stomach acid, digestive enzymes, and the liver’s filtering system before entering the bloodstream. By the time they reach target tissue, only a tiny fraction may remain. Scientists call this bioavailability, meaning the amount of a substance that actually reaches the body’s tissues and can exert effects.
Tumour biology varies, so lab results may not match patient tumours
Cancer is not a single disease but a collection of hundreds of diseases, and even patients with the same cancer type can have tumours driven by different genetic and molecular changes. Some breast cancers depend on hormones such as estrogen, while others rely on entirely different pathways, and patterns of spread can also differ between tumours. Because of these differences, treatments that work in a lab setting may not work the same way in individual patients.

Reading history

Hide →

This history is cleared when the page is closed.

Why do lab-grown cancer cells differ from those in the body?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends